Report Description

Biological safety testing involves testing of all vaccines and biopharmaceutical products to ensure that the product is safe and free from all contaminations. Government health authorities such as United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) undergo biological safety testing to ensure product safety. The global biological safety testing market is expected to have a CAGR of 13% during the forecast period 2016-2023. Increasing pharmaceutical and biotechnology industry primarily contributes to the growth of the global biological safety testing market during the forecast period. Moreover, increasing awareness regarding health among general population contributes to the growth of global biological safety testing market.

Drug launches in recent years mainly contributes to the growth of the global biological safety testing market. Development and manufacturing of advanced drugs in future will demand more effective and enhanced medicinal drug safety testing methods thus, contributing to the growth of the global biological safety testing market during the forecast period. Several new drugs have been launched in 2017. Tesaro is looking for its second FDA approval in 2017 whereas Neurocrine is looking for new cancer pill niraparib therapy. Moreover, Kite Pharma is aiming for approval of first-ever CAR-T cancer drug to market in 2017. Therefore, these drug launches will contribute to the growth of the global biological safety testing market during the forecast period.

Source: OBRC Analysis

The report on global biological safety testing market is segmented on the basis of product, test and applications.

Products in global biological safety testing market include:

Instruments
Kits and reagents
Services

Test in global biological safety testing market are further divided as:

Adventitious agent detection test
Bio burden test
Cell line authentication and characterization test
Endo toxin test
Residual host contamination detection test
Sterility test
Others

Applications of global biological safety testing market include:

Blood and blood related products testing
Cellular and gene therapy
Stem cell research
Tissue and tissue related products testing
Vaccine and Therapeutics development

The report scope is widely categorized on the basis of its segments such as product, test type and applications. Moreover, the market revenue estimates and forecast includes only the biological safety testing systems. However, report scope excludes other testing systems.

Geographically, the global biological safety testing market report is segmented into:

North America (U.S. & Canada)
Asia Pacific (China, India, Japan, RoAPAC)
Europe (UK, France, Germany, RoE)
Rest of World

North America accounted for the largest market share in terms of revenue for global biological safety testing market in 2016 followed by Europe. North America is expected to dominate the market during the forecast period. The growth in the region is witnessed owing to adoption of biotechnology in cancer research and development of new drugs, biologics and vaccines such as Zepatier, Briviact, Taltz etc. Asia Pacific is expected to be the fastest growing region for biological safety testing market during the forecast period due to presence of emerging economies such as China, India and South Korea, huge population, growth in biotechnology and pharmaceuticals industry, healthcare spending and adoption of low cost and compact techniques in research sector.

Global biological safety testing market report covers segmentation analysis of product, test and applications. Report further covers segments of product which include instruments, kits and reagents and services. Kits and reagents held the largest market share in terms of revenue for the biological safety testing market in 2016 and it is expected to dominate the segment during the forecast period. The growth of the segment is attributed to its high popularity and launch of more efficient technologies during the forecast period. Moreover, the test types in biological safety testing are divided as adventitious agent detection test, bio burden test, cell line authentication and characterization test, endo-oxin test, residual host contamination detection test, sterility test and other tests. The endo-toxin tests and sterility tests held the largest market share in terms of revenue in 2016 and it is expected to dominate the market during the forecast period owing to increasing awareness and implication of stringent regulations. Furthermore, the applications of biological safety testing include blood and blood related products testing, cellular and gene therapy, stem cell research, tissue and tissue related products testing and vaccine and therapeutic development. Vaccine and therapeutic development held the largest market share in terms of revenue in 2016 and is expected to dominate the market during the forecast period owing to rising prevalence of chronic diseases, increasing initiatives for immunization and increasing investments in vaccine development.

The major market players of the global biological safety testing market are:

LONZA GROUP LTD.
SGS SA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.
SARTORIUS AG
OTHERS

These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch whereas, mergers, partnerships and acquisitions is the key strategy adopted by the companies in the global biological safety testing market.

For example: In 2016, Charles River Laboratories acquired Blue Stream Laboratories, Inc. (analytical contract research industry). The major aim of the acquisition was to enhance the existing capabilities for the safety assessment and to manufacture biologics.

The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in the global biological safety testing market.

Key reasons to buy the report:

The report includes market estimation, forecast and analysis for the year 2016-2023 of the global biological safety testing market.
Report includes detailed analysis of different segments such as product, test and applications of the global biological safety testing market.
Identify and understand the strength, opportunities, challenges and threat of the global biological safety testing market during the forecast period.
Covers details analysis of Porters 5 force model and other strategic models. Also covers revenues, market share analysis, and competitive landscape analysis of major players of the global biological safety testing market.
Detailed analysis of various regulatory policies which affect the global biological safety testing market during the forecast period.

How are we different from others

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on the global biological safety testing market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the global biological safety testing market, with giving extensive SCOT analysis of key companies.

Key findings of the global biological safety testing market:

Increase in number of drug launches is adding growth in the global biological safety testing market during the forecast period.
North America held highest revenue share in 2016 and is expected to dominate the market during the forecast period.
Kits and reagents segment is expected to dominate the global biological safety testing market during the forecast period owing to its high popularity and launch of more efficient technologies.
Acquisition is the key strategy adopted by players of the global biological safety testing market during the forecast period.

Table of Content

1. INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

2.1. BIOLOGICAL SAFETY TESTING MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1. TOP 5 FINDINGS

2.5.2. TOP 5 OPPORTUNITY MARKETS

2.5.3. TOP 5 COMPANIES

2.5.4. TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1. INVESTMENT VS. ADOPTION MODEL

2.7.2. 360-DEGREE INDUSTRY ANALYSIS

2.7.3. PORTERS 5 FORCE MODEL

2.7.4. SEE-SAW ANALYSIS

2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1. KEY STRATEGIES & ANALYSIS

2.8.2. MARKET SHARE ANALYSIS AND TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1. INCREASING PREVALANCE OF CHRONIC DESEASES GLOBALLY

3.1.2. INCREASE IN NUMBER OF DRUG LAUNCHES

3.1.3. GROWTH OF BIOTECHNOLOGY AND BIOPHARMACEUTICALS INDUSTRIES

3.1.4. R & D INVESTMENTS IN LIFE SCIENCE

3.1.5. STRINGENT REGULATIONS ISSUED BY HEALTHCARE ORGANIZATIONS

3.2. MARKET RESTRAINTS

3.2.1. HIGH HEALTHCARE AND INVESTMENT COSTS

3.2.2. LACK OF REGULATORY FRAMEWORK

3.3. MARKET OPPORTUNITIES

3.3.1. INCREASING PHARMACEUTICAL OUTSOURCING

3.3.2. INCREASING APPLICATIONS IN THERAPEUTICS AND EXPANSION IN ASIA PACIFIC

3.4. MARKET CHALLENGES

3.4.1. LACK OF SKILLED PROFESSIONALS

4. MARKET SEGMENTATION

4.1.1. BIOLOGICAL SAFETY TESTING MARKET BY PRODUCT

4.1.2. MARKET DEFINITION AND SCOPE

4.1.3. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.1.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.1.5. OPPORTUNITY MATRIX

4.1.6. MARKET SEGMENTATION

4.1.6.1. GLOBAL INSTRUMENTS MARKET

4.1.6.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.1.3. TOP PLAYERS & KEY PRODUCTS

4.1.6.1.4. KEY CONCLUSIONS

4.1.6.2. GLOBAL KITS AND REAGENTS MARKET

4.1.6.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.2.3. TOP PLAYERS & KEY PRODUCTS

4.1.6.2.4. KEY CONCLUSIONS

4.1.6.3. GLOBAL SERVICES MARKET

4.1.6.3.1. APPLICATION

4.1.6.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.3.4. TOP PLAYERS & KEY PRODUCTS

4.1.6.3.5. KEY CONCLUSIONS

4.2. BIOLOGICAL SAFETY TESTING MARKET BY TEST TYPE

4.2.1. MARKET DEFINITION AND SCOPE

4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.2.4. OPPORTUNITY MATRIX

4.2.5. MARKET SEGMENTATION

4.2.5.1. GLOBAL ADVENTITIOUS AGENT DETECTION TESTS MARKET

4.2.5.1.1. APPLICATION

4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.1.5. KEY CONCLUSIONS

4.2.5.2. GLOBAL BIOBURDEN TESTS MARKET

4.2.5.2.1. APPLICATION

4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.2.5. KEY CONCLUSIONS

4.2.5.3. GLOBAL CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS MARKET

4.2.5.3.1. APPLICATION

4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.3.5. KEY CONCLUSIONS

4.2.5.4. GLOBAL ENDOTOXIN TESTS MARKET

4.2.5.4.1. APPLICATION

4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.4.5. KEY CONCLUSIONS

4.2.5.5. GLOBAL RESIDUAL HOST CONTAMINATION DETECTION TESTS MARKET

4.2.5.5.1. APPLICATION

4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.5.5. KEY CONCLUSIONS

4.2.5.6. GLOBAL STERILITY TESTS MARKET

4.2.5.6.1. APPLICATION

4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.6.5. KEY CONCLUSIONS

4.2.5.7. GLOBAL OTHERS MARKET

4.2.5.7.1. APPLICATION

4.2.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.7.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.7.5. KEY CONCLUSIONS

4.3. BIOLOGICAL SAFETY TESTING MARKET BY APPLICATION

4.3.1. MARKET DEFINITION AND SCOPE

4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.3.4. OPPORTUNITY MATRIX

4.3.5. MARKET SEGMENTATION

4.3.5.1. GLOBAL BLOOD AND BLOOD RELATED PRODUCTS TESTING MARKET

4.3.5.1.1. APPLICATION

4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.1.5. KEY CONCLUSIONS

4.3.5.2. GLOBAL CELLULAR AND GENE THERAPY MARKET

4.3.5.2.1. APPLICATION

4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.2.5. KEY CONCLUSIONS

4.3.5.3. GLOBAL STEM CELL RESEARCH MARKET

4.3.5.3.1. APPLICATION

4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.3.5. KEY CONCLUSIONS

4.3.5.4. GLOBAL TISSUE AND TISSUE RELATED PRODUCTS TESTING MARKET

4.3.5.4.1. APPLICATION

4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.4.5. KEY CONCLUSIONS

4.3.5.5. GLOBAL VACCINE AND THERAPEUTICS DEVELOPMENT MARKET

4.3.5.5.1. APPLICATION

4.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.5.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.5.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIES

5.1.1. LIST OF MERGERS AND ACQUISITION

5.1.2. LIST OF JOINT VENTURES

5.1.3. LIST OF PRODUCT LAUNCHES

5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHICAL ANALYSIS

6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.3. OPPORTUNITY MATRIX

6.4. GLOBAL BIOLOGICAL SAFETY TESTING MARKET BY REGION 2014-2023 ($ MILLION)

6.4.1. NORTH AMERICA

6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)

6.4.1.2. TOP COUNTRY ANALYSIS

6.4.1.2.1. U.S.

6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.1.3. KEY CONCLUSIONS

6.4.1.2.2. CANADA

6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.2.3. KEY CONCLUSIONS

6.4.2. EUROPE

6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)

6.4.2.2. TOP COUNTRY ANALYSIS

6.4.2.2.1. UK

6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.1.3. KEY CONCLUSIONS

6.4.2.2.2. FRANCE

6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.2.3. KEY CONCLUSIONS

6.4.2.2.3. GERMANY

6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.3.3. KEY CONCLUSIONS

6.4.2.2.4. SPAIN

6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.4.3. KEY CONCLUSIONS

6.4.2.2.5. REST OF EUROPE

6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.5.3. KEY CONCLUSIONS

6.4.3. ASIA PACIFIC

6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)

6.4.3.2. TOP COUNTRY ANALYSIS

6.4.3.2.1. CHINA

6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.1.3. KEY CONCLUSIONS

6.4.3.2.2. INDIA

6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.2.3. KEY CONCLUSIONS

6.4.3.2.3. JAPAN

6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.3.3. KEY CONCLUSIONS

6.4.3.2.4. AUSTRALIA

6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.4.3. KEY CONCLUSIONS

6.4.3.2.5. REST OF ASIA PACIFIC

6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.5.3. KEY CONCLUSIONS

6.4.4. ROW

6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)

6.4.4.2. TOP COUNTRY ANALYSIS

6.4.4.2.1. LATIN AMERICA

6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.1.3. KEY CONCLUSIONS

6.4.4.2.2. MIDDLE EAST & AFRICA

6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

7.1. LONZA GROUP LTD. (SWITZERLAND)

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY INNOVATION SECTOR

7.1.4. STRATEGIC INITIATIVES

7.1.5. SCOT ANALYSIS

7.1.6. STRATEGIC ANALYSIS

7.2. CHARLES RIVER LABORATORIES (U.S.)

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY INNOVATION SECTOR

7.2.4. STRATEGIC INITIATIVES

7.2.5. SCOT ANALYSIS

7.2.6. STRATEGIC ANALYSIS

7.3. MERCK KGAA (GERMANY)

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY INNOVATION SECTOR

7.3.4. STRATEGIC INITIATIVES

7.3.5. SCOT ANALYSIS

7.3.6. STRATEGIC ANALYSIS

7.4. SGS SA (SWITZERLAND)

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY INNOVATION SECTOR

7.4.4. STRATEGIC INITIATIVES

7.4.5. SCOT ANALYSIS

7.4.6. STRATEGIC ANALYSIS

7.5. WUXI APPTEC (CHINA)

7.5.1. OVERVIEW

7.5.2. PRODUCT PORTFOLIO

7.5.3. KEY INNOVATION SECTOR

7.5.4. STRATEGIC INITIATIVES

7.5.5. SCOT ANALYSIS

7.5.6. STRATEGIC ANALYSIS

7.6. THERMO FISHER SCIENTIFIC INC. (U.S.)

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY INNOVATION SECTOR

7.6.4. STRATEGIC INITIATIVES

7.6.5. SCOT ANALYSIS

7.6.6. STRATEGIC ANALYSIS

7.7. SARTORIUS AG (GERMANY)

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY INNOVATION SECTOR

7.7.4. STRATEGIC INITIATIVES

7.7.5. SCOT ANALYSIS

7.7.6. STRATEGIC ANALYSIS

7.8. CYTOVANCE BIOLOGICS INC. (U.S.)

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY INNOVATION SECTOR

7.8.4. STRATEGIC INITIATIVES

7.8.5. SCOT ANALYSIS

7.8.6. STRATEGIC ANALYSIS

7.9. PACE ANALYTICAL SERVICES INC. (U.S.)

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY INNOVATION SECTOR

7.9.4. STRATEGIC INITIATIVES

7.9.5. SCOT ANALYSIS

7.9.6. STRATEGIC ANALYSIS

7.10. TOXIKON CORPORATION (U.S.)

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY INNOVATION SECTOR

7.10.4. STRATEGIC INITIATIVES

7.10.5. SCOT ANALYSIS

7.10.6. STRATEGIC ANALYSIS

7.11. AVANCE BIOSCIENCES (U.S.)

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY INNOVATION SECTOR

7.11.4. STRATEGIC INITIATIVES

7.11.5. SCOT ANALYSIS

7.11.6. STRATEGIC ANALYSIS

7.12. NUAIRE (U.S.)

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY INNOVATION SECTOR

7.12.4. STRATEGIC INITIATIVES

7.12.5. SCOT ANALYSIS

7.12.6. STRATEGIC ANALYSIS

7.13. PARAGON BIOSERVICES INC. (U.S.)

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY INNOVATION SECTOR

7.13.4. STRATEGIC INITIATIVES

7.13.5. SCOT ANALYSIS

7.13.6. STRATEGIC ANALYSIS

7.14. NORDIC SCIENTIFIC AND NATURAL SOLUTIONS AB (SWEDEN)

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY INNOVATION SECTOR

7.14.4. STRATEGIC INITIATIVES

7.14.5. SCOT ANALYSIS

7.14.6. STRATEGIC ANALYSIS

7.15. SOURCE BIOSCIENCE (U.K.)

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY INNOVATION SECTOR

7.15.4. STRATEGIC INITIATIVES

7.15.5. SCOT ANALYSIS

7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

1. GLOBAL BIOLOGICAL SAFETY TESTING MARKET BY PRODUCT 2014-2023 ($ MILLION)

2. GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

3. GLOBAL KITS AND REAGENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

4. GLOBAL SERVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

5. GLOBAL BIOLOGICAL SAFETY TESTING MARKET BY TEST TYPE 2014-2023 ($ MILLION)

6. GLOBAL ADVENTITIOUS AGENT DETECTION TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

7. GLOBAL BIOBURDEN TESTS FORENSICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

8. GLOBAL CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

9. GLOBAL ENDOTOXIN TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

10. GLOBAL RESIDUAL HOST CONTAMINATION DETECTION TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

11. GLOBAL STERLITY TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

12. GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

13. GLOBAL BIOLOGICAL SAFETY TESTING MARKET BY APPLICATION 2014-2023 ($ MILLION)

14. GLOBAL BLOOD AND BLOOD RELATED PRODUCTS TESTING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

15. GLOBAL CELLULAR AND GENE THERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

16. GLOBAL STEM CELL RESEARCH MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

17. GLOBAL TISSUE AND TISSUE RELATED PRODUCTS TESTING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

18. GLOBAL VACCINE AND THERAPEUTICS DEVELOPMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

19. NORTH AMERICA BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

20. EUROPE BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

21. ASIA PACIFIC BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

22. REST OF THE WORLD BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

1. GLOBAL BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

2. GLOBAL INSTRUMENTS MARKET 2014-2023 ($ MILLION)

3. GLOBAL KITS AND REAGENTS MARKET 2014-2023 ($ MILLION)

4. GLOBAL SERVICES MARKET 2014-2023 ($ MILLION)

5. GLOBAL ADVENTITIOUS AGENT DETECTION TESTS MARKET 2014-2023 ($ MILLION)

6. GLOBAL BIOBURDEN TESTS FORENSICS MARKET 2014-2023 ($ MILLION)

7. GLOBAL CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS MARKET 2014-2023 ($ MILLION)

8. GLOBAL ENDOTOXIN TESTS MARKET 2014-2023 ($ MILLION)

9. GLOBAL RESIDUAL HOST CONTAMINATION DETECTION TESTS MARKET 2014-2023 ($ MILLION)

10. GLOBAL STERLITY TESTS MARKET 2014-2023 ($ MILLION)

11. GLOBAL OTHERS MARKET 2014-2023 ($ MILLION)

12. GLOBAL BLOOD AND BLOOD RELATED PRODUCTS TESTING MARKET 2014-2023 ($ MILLION)

13. GLOBAL CELLULAR AND GENE THERAPY MARKET 2014-2023 ($ MILLION)

14. GLOBAL STEM CELL RESEARCH MARKET 2014-2023 ($ MILLION)

15. GLOBAL TISSUE AND TISSUE RELATED PRODUCTS TESTING MARKET 2014-2023 ($ MILLION)

16. GLOBAL VACCINE AND THERAPEUTICS DEVELOPMENT MARKET 2014-2023 ($ MILLION)

17. UNITED STATES (U.S.) BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

18. CANADA BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

19. UNITED KINGDOM (UK) BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

20. FRANCE BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

21. GERMANY BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

22. SPAIN BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

23. ROE BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

24. INDIA BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

25. CHINA BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

26. JAPAN BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

27. AUSTRALIA BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

28. ROAPAC BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

29. LATIN AMERICA BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

30. MENA BIOLOGICAL SAFETY TESTING MARKET 2014-2023 ($ MILLION)

Enquiry before Buying

FAQ

How can I purchase a report?

We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.

How safe is to use my credit card? Is my information secure?

We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.

Can I get a discount?

We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.

I want to buy only a chapter. I don't need complete report.

Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.

Can I get reports on my desired topic specially which is not available in your current portfolio?

Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.

When do I get access to the report(s) that I have purchased?

We will email you your purchased report right after we receive your payment through any of the payment options.

Will I receive any invoice for my purchase?

Yes we will email you invoice/payment confirmation with the order details once we receive your payment.

In what format will the reports be available in?

All the reports will be available in PDF format for download.

Request for Sample

Name*

Email Id*

Phone

Designation

Company Name

Country

Report Title

Type Characters*

Login

Forgot Password

Thank you for your request!

Thank you for downloading..!

Global Biological Safety Testing Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

FAQ

Request for Sample

UPCOMING REPORTS

NAVIGATION LINK

OUR SERVICES

CONNECT WITH US